SHC

Sotera HealthB

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-06-11

View Chart

AI scenario view

RankAlpha Sentiment AI

B+

Bull case

20%

Probability

Target price

$26.46

+60.1% vs current

Most likely

Base case

60%

Probability

Target price

$17.64

+6.7% vs current

B-

Bear case

20%

Probability

Target price

$12.35

-25.3% vs current

AI sentiment snapshot

Latest data as of 2026-01-01

AI commentary

Market tone is cautiously mixed: investors note recent secondary offering pressure and European pricing headwinds disclosed in the Q3 release and 10‑Q [#PR-2025-10-15, #PR-2025-11-06, #10Q-2025Q3]. Commentary from management about margin programs and guidance narrowing tempers outright pessimism but keeps expectations guarded [#PR-2025-11-06]. Overall sentiment remains neutral-to-slightly-negative until clearer operational or refinancing evidence emerges.

RankAlpha Sentiment AI - 2026-01-01

Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact

standard

Confidence

AI events

2026-04-01catalystQ4 / Full-Year 2025 Earnings ReleaseHigh impact

Company to report Q4 and full‑year 2025 results; management previously discussed guidance narrowing and regional pricing/headwind commentary in the Q3 release [#PR-2025-11-06] and in the Q3 2025 Form 10‑Q [#10Q-2025Q3].

2026-04-01catalystSecondary Offering / Float Overhang ContinuesMedium impact

Selling stockholders completed an upsized secondary on Oct 15, 2025; additional secondary-related supply and residual selling pressure may persist and weigh on near‑term liquidity/float [#PR-2025-10-15] and is disclosed in the Q3 2025 10‑Q as a share‑count/float factor [#10Q-2025Q3].

2026-12-31event2026 Debt Maturities / Refinancing RequirementHigh impact

The Q3 2025 Form 10‑Q discloses term‑loan principal scheduled in 2026; refinance or repayment terms could force covenant pressure or higher financing costs if liquidity tightens (window end used per disclosure) [#10Q-2025Q3].

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2026-01-01 • Updated nightlySource: Internal modelMethodology